Vicore Pharma Holding AB (publ) Cash Flow-to-Debt Ratio
Vicore Pharma Holding AB (publ) cash flow-to-debt ratio. Vicore Pharma Holding AB (publ) (VICO) has a Cash Flow-to-Debt Ratio of -0.66x as of December 2025, meaning its operating cash flow of Skr-81.48 Million could theoretically repay -1% of its total liabilities (Skr124.16 Million) in one year. Check Vicore Pharma Holding AB (publ) (VICO) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Vicore Pharma Holding AB (publ) (2012–2025)
Cash flow-to-debt ratio of Vicore Pharma Holding AB (publ) from 2012 to 2025. Historical debt coverage capacity for Vicore Pharma Holding AB (publ) across 14 annual periods. Check Vicore Pharma Holding AB (publ) investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Vicore Pharma Holding AB (publ) Cash Flow-to-Debt Ratio by Year (2012–2025)
Vicore Pharma Holding AB (publ) cash flow-to-debt ratio by year from 2012 to 2025. Year-by-year debt coverage analysis for Vicore Pharma Holding AB (publ). For the full cash flow conversion analysis, see VICO cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.02x | Skr-374.44 Million | Skr124.16 Million | ▼ -34.9% |
| 2024 | -2.24x | Skr-164.95 Million | Skr73.78 Million | ▲ +62.0% |
| 2023 | -5.88x | Skr-249.58 Million | Skr42.45 Million | ▲ +4.1% |
| 2022 | -6.13x | Skr-299.92 Million | Skr48.92 Million | ▼ -56.9% |
| 2021 | -3.91x | Skr-265.17 Million | Skr67.85 Million | ▼ -69.4% |
| 2020 | -2.31x | Skr-119.94 Million | Skr52.00 Million | ▲ +48.3% |
| 2019 | -4.46x | Skr-87.00 Million | Skr19.51 Million | ▼ -118.2% |
| 2018 | -2.04x | Skr-33.04 Million | Skr16.16 Million | ▼ -74.0% |
| 2017 | -1.17x | Skr-7.71 Million | Skr6.56 Million | ▲ +1.9% |
| 2016 | -1.20x | Skr-7.25 Million | Skr6.05 Million | ▼ -137.3% |
| 2015 | -0.50x | Skr-3.68 Million | Skr7.29 Million | ▼ -1.3% |
| 2014 | -0.50x | Skr-2.83 Million | Skr5.67 Million | ▼ -204.8% |
| 2013 | -0.16x | Skr-1.79 Million | Skr10.97 Million | ▼ -18.4% |
| 2012 | -0.14x | Skr-1.67K | Skr12.09K | — |